NEWS

HomeNEWSCorporate News

Zhonghong Medical Technology Center Rated as A Model Role by Hebei Development and Reform Commission

2022-09-02

On August 29th, the Development and Reform Commission of Hebei Province released the evaluation results of Hebei Enterprise Technology Center in 2022, and the Technology Center of Zhonghong Pulin Medical Products Co., Ltd. (referred to as Zhonghong Medical), a subsidiary of Zhonghong Pulin Group, scored 90.4 points and was rated as excellent.




According to the intent of the Second Plenary Session of the Tenth Central Committee of CPC Hebei Provincial Committee,  it is necessary to strengthen the leading role of innovation drive, accelerate the upgrading of the technological innovation capability of strategic emerging industries and leading industries in the province to promote the construction of a modern industrial system. As an important supporting platform for innovation-driven development and industrial transformation and upgrading in Hebei Province, the provincial enterprise technology center is an important position for tackling key industrial technologies. The evaluation of the Enterprise Technology Center in Hebei Province in 2022 was based on the Administrative Measures of Enterprise Technology Center in Hebei Province and Several Opinions on Accelerating the Promotion of Industrial Innovation Ability in Hebei Province. The Provincial Development and Reform Commission commissioned third-party organizations to organize experts to review and score the provincial enterprise technology centers recognized before 2020. A total of 666 provincial enterprise technology centers in Hebei Province participated in the evaluation, of which only 84 scored no less than 90 points  and were evaluated as excellent.

Zhonghong Medical always attaches importance to technological innovation, product research and development and recruitment of new talented professionals. In recent years, with the support of the provincial enterprise technology center, Zhonghong Medical has established business relationship with Chinese Academy of Sciences, Beijing University of Chemical Technology, North China University of Science and Technology and other institutions of higher learning, in order to set up professional R&D teams and enhance technological innovation capabilities through the combination of industry, universities and research institutes based on the research resources of professional colleges. Zhonghong Medical Hainan Subsidiary was also established to build a medical achievement commercialization and R&D platform. So far, the company has continuously improved its technological innovation system and innovation platform development. It has developed 53 patented products, and will continue to apply for patents for its developed products.


Share it on wechat Share it on Weibo